Literature DB >> 6275562

Epstein-Barr (EB) virus antibodies in rheumatoid arthritis.

P B Ferrell, E M Tan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6275562     DOI： 10.1007/bf01857094

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  17 in total

1.  Antinuclear reactivity of sera in patients with leukemia and other neoplastic diseases.

Authors:  M Seiner; E Klein; G Klein
Journal:  Clin Immunol Immunopathol       Date:  1975-09

2.  Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Demonstration by precipitation and immunofluorescence.

Authors:  M A Aslpaugh; E M Tan
Journal:  Arthritis Rheum       Date:  1976 Jul-Aug

3.  The spectrum of infections with Epstein-Barr virus: a hypothesis.

Authors:  A S Evans
Journal:  J Infect Dis       Date:  1971-09       Impact factor: 5.226

4.  Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus-infected cells.

Authors:  G Henle; W Henle; G Klein
Journal:  Int J Cancer       Date:  1971-09-15       Impact factor: 7.396

5.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

6.  Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis.

Authors:  M A Catalano; D A Carson; S F Slovin; D D Richman; J H Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

7.  Antibody to the rheumatoid arthritis nuclear antigen. Its relationship to in vivo Epstein-Barr virus infection.

Authors:  M A Catalano; D A Carson; J C Niederman; P Feorino; J H Vaughan
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

8.  Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures.

Authors:  D J Moss; A B Rickinson; J H Pope
Journal:  Int J Cancer       Date:  1979-05-15       Impact factor: 7.396

9.  The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies.

Authors:  E L Reinherz; C O'Brien; P Rosenthal; S F Schlossman
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

10.  Increased sensitivity of human lymphoid lines to natural killer cells after induction of the Epstein-Barr viral cycle by superinfection or sodium butyrate.

Authors:  B Blazar; M Patarroyo; E Klein; G Klein
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307
View more
  4 in total

1.  A model for the role of HLA-DQ molecules in the pathogenesis of juvenile chronic arthritis.

Authors:  J P Haas; A Andreas; B Rutkowski; H Brunner; E Keller; J Hoza; S Havelka; G Sierp; E D Albert
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

Review 2.  Autoimmune diseases: immunopathology and etiopathogenesis.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1982-09       Impact factor: 4.307

3.  Increased responsiveness of rheumatoid B lymphocytes to stimulation by Epstein-Barr virus.

Authors:  H E Stierle; K A Brown; J D Perry; E J Holborow
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

4.  Antibody Responses to Epstein-Barr Virus in the Preclinical Period of Rheumatoid Arthritis Suggest the Presence of Increased Viral Reactivation Cycles.

Authors:  Sabrina Fechtner; Heather Berens; Elizabeth Bemis; Rachel L Johnson; Carla J Guthridge; Nichole E Carlson; M Kristen Demoruelle; John B Harley; Jess D Edison; Jill A Norris; William H Robinson; Kevin D Deane; Judith A James; V Michael Holers
Journal:  Arthritis Rheumatol       Date:  2022-02-13       Impact factor: 10.995
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.